Apo and inhibitor complex structures of BACE (β-secretase)

Journal of Molecular Biology

Volumn 343, Issue 2, 2004, Pages 407-416

  Patel, Sahil ^a   Vuillard, Laurent ^a   Cleasby, Anne ^a   Murray, Christopher W ^a   Yon, Jeff ^a  

^a ASTEX PHARMACEUTICALS   (United Kingdom)

Author keywords

Alzheimer's disease; BACE; crystallography; drug discovery

Indexed keywords

AMINE; BETA SECRETASE; HYDROXYETHYLAMINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; DRUG DESIGN; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN TARGETING; STATISTICAL SIGNIFICANCE;

EID: 4644364822     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2004.08.018     Document Type: Article

References (51)

1. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
2. D.I. Dominguez, and B. De Strooper Novel therapeutic strategies provide the real test for the amyloid hypothesis of Alzheimer's disease Trends Pharmacol. Sci. 23 2002 324 330
3. V. John, J.P. Beck, M.J. Bienkowski, S. Sinha, and R.L. Heinrikson Human β-secretase (BACE) and BACE inhibitors J. Med. Chem. 46 2003 4625 4630
4. I. Hussain, D. Powell, D. Howlett, D.G. Tew, T.D. Meek, and C. Chapman Identification of a novel aspartic protease (Asp2) as β-secretase Mol. Cell. Neurosci. 14 1999 419 427
5. X. Lin, G. Koelsch, S. Wu, D. Downs, A. Dashti, and J. Tang Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein Proc. Natl Acad. Sci USA 97 2000 1456 1460
6. S. Sinha, J.P. Anderson, R. Barbour, G.S. Basi, R. Caccavello, and D. Davis Purification and cloning of amyloid precursor protein β-secretase from human brain Nature 402 1999 537 540
7. R. Vassar, B.D. Bennett, S. Babu-Khan, S. Kahn, E.A. Mendiaz, and P. Denis β-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE Science 286 1999 735 741
8. H. Cai, Y. Wang, D. McCarthy, H. Wen, D.R. Borchelt, and D.L. Price BACE1 is the major beta-secretase for generation of Aβ peptides by neurons Nature Neurosci. 4 2001 233 234
9. Y. Luo, B. Bolon, S. Kahn, B.D. Bennett, S. Babu-Khan, and P. Denis Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation Nature Neurosci. 4 2001 231 232
10. M. Ohno, E.A. Sametsky, L.H. Younkin, H. Oakley, S.G. Younkin, and M. Citron BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease Neuron 41 2004 27 33
11. L. Hong, G. Koelsch, X. Lin, S. Wu, S. Terzyan, and A.K. Ghosh Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor Science 290 2000 150 153
12. L. Hong, R.T. Turner III, G. Koelsch, G. Shin, A.K. Ghosh, and J. Tang Crystal structure of memapsin 2 (β-secretase) complexed with an inhibitor OM00-3 Biochemistry 41 2002 10963 10967
13. J. Tang, A.K. Ghosh, L. Hong, G. Koelsch, R.T. Turner III, and W. Chang Study of memapsin 2 (β-secretase) and strategy of inhibitor design J. Mol. Neurosci. 20 2003 299 304
14. R. Carr, and H. Jhoti Structure-based screening of low-affinity compounds Drug Discov. Today 7 2002 522 527
15. M.G. Bursavich, and D.H. Rich Designing non-peptide peptidomimetics in the 21st century: inhibitors targeting conformational ensembles J. Med. Chem. 45 2002 541 558
16. S. Roggo Inhibition of BACE, a promising approach to Alzheimer's disease therapy Curr. Top. Med. Chem. 2 2002 359 370
17. R.K. Hom, L.Y. Fang, S. Mamo, J.S. Tung, A.C. Guinn, and D.E. Walker Design and synthesis of statine-based cell-permeable inhibitors of human β-secretase J. Med. Chem. 46 2003 1799 1802
18. *-Ala-based pentapeptide mimetics are BACE inhibitors: P2 and P3 SAR Bioorg. Med. Chem. Letters 14 2004 239 243
19. V. Sardana, B. Xu, J. Zugay-Murphy, Z. Chen, M. Sardana, and P.L. Darke A general procedure for the purification of human β-secretase expressed in Escherichia coli Protein Expr. Purif. 34 2004 190 196
20. W. Bruinzeel, J. Yon, S. Giovanelli, and S. Masure Recombinant insect cell expression and purification of human β-secretase (BACE-1) for X-ray crystallography Protein Expr. Purif. 26 2002 139 148
21. B.D. Bennett, P. Denis, M. Haniu, D. Teplow, S. Kahn, and J-C. Louis A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's β-secretase J. Biol. Chem. 275 2000 37712 37717
22. J. Ermolieff, J.A. Loy, G. Koelsch, and J. Tang Proteolytic activation of recombinant pro-memapsin 2 (pro-β-secretase) studied with new fluorogenic substrates Biochemistry 39 2000 12450 12456
23. J. Raheul, V. Rasetti, J. Maibaum, H. Rüger, R. Göschke, and N.-C. Cohen Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin Chem. Biol. 7 2000 493 504
24. J.M. Wood, J. Maibaum, J. Raheul, M.G. Grütter, N.-C. Cohen, and V. Rasetti Structure-based design of aliskiren, a novel orally effective renin inhibitor Biochem. Biophys. Res. Commun. 308 2003 698 705
25. L. Hong, and J. Tang Flap position of free memapsin 2 (β-secretase), a model for flap opening in aspartic protease catalysis Biochemistry 43 2004 4689 4695
26. G.L. Gilliland, E.L. Winborne, J. Nachman, and A. Wlodawer The three-dimensional structure of recombinant bovine chymosin at 2.3 A resolution Proteins: Struct. Funct. Genet. 8 1990 82 101
27. C. Oefner, A. Binggelli, V. Breu, J-P. Clozel, A. D'Arcy, and A. Dorn Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteases? Chem. Biol. 6 1999 127 131
28. R. Güller, A. Binggelli, V. Breu, D. Bur, W. Fischli, and G. Hirth Piperidine-renin inhibitors with improved physicochemical properties Bioorg. Med. Chem. Letters 9 1999 1403 1408
29. E. Vieira, A. Binggelli, V. Breu, D. Bur, W. Fischli, and R. Güller Substituted piperidines - highly potent renin inhibitors due to induced fit adaption of the active site Bioorg. Med. Chem. Letters 9 1999 1397 1402
30. D.A. Carcache, S.R. Hortner, P. Seiler, F. Diederich, A. Dorn, and H.P. Märki Development of a new class of inhibitors for the malarial aspartic protease plasmepsin II based on a central 7-azabicyclo[2.2.1]heptane scaffold Helvet. Chim. Acta 86 2003 2173 2191
31. D.W. Banner, and P. Hadvary Crystallographic analysis at 3.0 A resolution of the binding to human thrombin of four active site-directed inhibitors J. Biol. Chem. 266 2008 5 20093
32. Collaborative Computational Project, Number 4 The CCP4 suite: programs for protein crystallography Acta Crystallog. sect. D 50 1994 760 763
33. A.G.W. Leslie Recent changes to the MOSFLM package for processing film and image plate data Joint CCP4+ESF-EAMCB Newsletter on Protein Crystallography No. 26 1992 Daresbury Laboratory Warrington, UK
34. C.R. Kissinger, D.K. Gehlhaar, and D.B. Fogel Rapid automated molecular replacement by evolutionary search Acta Crystallog. sect. D 55 1999 484 491
35. A. Perrakis, T.K. Sixma, K.S. Wilson, and V.S. Lamzin wARP: improvement and extension of crystallographic phases by weighted averaging of multiple refined dummy atomic models Acta Crystallog. sect. D 53 1997 448 455
36. M.J. Hartshorn AstexViewer: a visualisation aid for structure-based drug design J. Comput. Aided Mol. Des. 16 2002 871 881
37. R.A. Laskowski, D.S. Moss, and J.M. Thornton Main-chain bond lengths and bond angles in protein structures J. Mol. Biol. 231 1993 1049 1067
38. M. Fujinaga, M.M. Chernaia, N.I. Tarasova, S.C. Mosimann, and M.N. James Crystal structure of human pepsin and its complex with pepstatin Protein Sci. 4 1995 960 972
39. A.R. Sielecki, A.A. Fedorov, A. Boodhoo, N.S. Andreeva, and M.N. James Molecular and crystal structures of monoclinic porcine pepsin refined at 1.8 Å resolution J. Mol. Biol. 214 1990 143 170
40. J.B. Cooper, G. Khan, G. Taylor, I.J. Tickle, and T.L. Blundell X-ray analyses of aspartic proteinases. II. Three-dimensional structure of the hexagonal crystal form of porcine pepsin at 2.3 Å resolution J. Mol. Biol. 214 1990 199 222
41. V. Dhanaraj, C.G. Dealwis, C. Frazao, M. Badasso, B.L. Sibanda, and I.J. Tickle X-ray analyses of peptide-inhibitor complexes define the structural basis of specificity for human and mouse renins Nature 357 1992 466 472
42. A.R. Sielecki, K. Hayakawa, M. Fujinaga, M.E. Murphy, M. Fraser, and A.K. Muir Structure of recombinant human renin, a target for cardiovascular-active drugs, at 2.5 Å resolution Science 243 1989 1346 1351
43. E.T. Baldwin, T.N. Bhat, S. Gulnik, M.V. Hosur, R.C. Sowder, and R.E. Cachau Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design Proc. Natl Acad. Sci. USA 90 1993 6796 6800
44. S.W. Cho, N. Kim, M.U. Choi, and W. Shin Structure of aspergillopepsin I from Aspergillus phoenicis: variations of the S1′-S2 subsite in aspartic proteinases Acta Crystallog. sect. D 57 2001 948 956
45. L. Pearl, and T. Blundell The active site of aspartic proteinases FEBS Letters 174 1984 96 101
46. M. Newman, F. Watson, P. Roychowdhury, H. Jones, M. Badasso, and A. Cleasby X-ray analyses of aspartic proteinases. V. Structure and refinement at 2.0 A resolution of the aspartic proteinase from Mucor pusillus J. Mol. Biol. 230 1993 260 283
47. J. Yang, A. Teplyakov, and J.W. Quail Crystal structure of the aspartic proteinase from Rhizomucor miehei at 2.15 Å resolution J. Mol. Biol. 268 1997 449 459
48. K. Suguna, R.R. Bott, E.A. Padlan, E. Subramanian, S. Sheriff, G.H. Cohen, and D.R. Davies Structure and refinement at 1.8 Å resolution of the aspartic proteinase from Rhizopus chinensis J. Mol. Biol. 196 1987 877 900
49. A. Gustchina, M. Li, L.H. Phylip, W.E. Lees, J. Kay, and A. Wlodawer An unusual orientation for Tyr75 in the active site of the aspartic proteinase from Saccharomyces cerevisiae Biochem. Biophys. Res. Commun. 295 2002 1020 1026
50. S. Kamitori, A. Ohtaki, H. Ino, and M. Takeuchi Crystal structures of Aspergillus oryzae aspartic proteinase and its complex with an inhibitor pepstatin at 1.9 Å resolution J. Mol. Biol. 326 2003 1503 1511
51. M.N. James, and A.R. Sielecki Structure and refinement of penicillopepsin at 1.8 Å resolution J. Mol. Biol. 163 1983 299 361